NCT07875283

Brief Summary

Endoscopic sleeve gastroplasty (ESG) is a new mini-invasive technique proposed to treat obesity (1-5). According to the endoscopic procedure compared to videolaparoscopy, this technique is supposed less painful and provide a reduction in postoperative complications (6-7). There are rare informations about the influence of ESG on postoperative painful (8). In this observational pilot study, the investigators prospectively assessed the postoperative analgesia concerns for this recent technique. The authors evaluated the pain relief, including morphine consumption, pain and satisfaction scores and morbidity following a new endoscopic sleeve gastroplasty scheduled on the first 100 consecutive patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
6.1 years until next milestone

First Submitted

Initial submission to the registry

October 5, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 15, 2026

Completed
Last Updated

October 15, 2026

Status Verified

October 1, 2026

Enrollment Period

2.7 years

First QC Date

October 5, 2026

Last Update Submit

October 8, 2026

Conditions

Keywords

painendoscopic sleevepostoperative

Outcome Measures

Primary Outcomes (1)

  • postoperative Morphine consumption

    Morphine consumption following the endoscopic sleeve gastroplasty

    first day postoperative period

Secondary Outcomes (2)

  • postoperative pain scores

    first day postoperative period

  • number of patient requiring morphine

    first day postoperative period

Other Outcomes (1)

  • postoperative nausea and vomiting

    first day postoperative period

Interventions

The first 100 consecutive patients scheduled to undergo ESG performed by the same operator (LK) according to a standardized technique, were included (Apollo Endosurgery, UK, Ltd). All the patients were informed and gave their consentment. After premedication using oral hydroxyzine, the anesthesia was standardized using intravenous sufentanil, propofol, dexamethasone and succinylcholine to facilitate oral tracheal intubation using videolaryngoscopy (MacGrath). After to control empty stomach without injury by initial endoscopy, a dose of intravenous atracurium was administered to help mechanical ventilation during stomach continuous CO2 insufflation and its EtCO2 monitoring. Anesthesia is maintained using sevoflurane inhalation, adjusted to get a 40-60 on the bispectral index of the electroencephalogram (BIS, Aspect Medical Systems, Newton, MA). Before discontinuation of volatile anesthetic and tracheal extubation, the postoperative analgesia was started using intravenous paracetamol 1 g

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The first 100 consecutive adult patients scheduled to undergo ESG performed by the same operator (LK) according to a standardized technique, were included (Apollo Endosurgery, UK, Ltd). All the patients were informed and gave their consentment.

You may qualify if:

  • Endoscopic sleeve gastroplasty Obesity adult patient

You may not qualify if:

  • previous bariatric surgery (Kuzmack gastric band, sleeve or bypass) patient older less 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

American Hospital of Paris

Neuilly-sur-Seine, 92200, France

Location

Related Publications (6)

  • Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA; ATLANTIS trialists. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 Nov 11;402(10414):1773-1785. doi: 10.1016/S0140-6736(23)01523-4. Epub 2023 Oct 16.

    PMID: 37858323BACKGROUND
  • Moy BM, Volk S, Richards B, Guduguntla BA, Schulman AR. Use of Postoperative Opioid Therapy Following Endoscopic Sleeve Gastroplasty. Am J Gastroenterol. 2024 Jun;119(6):1186-1181. doi: 10.14309/ajg.0000000000002665. Epub 2024 Feb 23.

    PMID: 38235688BACKGROUND
  • Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castano I, Acosta A, Topazian MD, Mundi MS, Kumta N, Kahaleh M, Herr AM, Shukla A, Aronne L, Gostout CJ, Abu Dayyeh BK. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017 Oct;27(10):2649-2655. doi: 10.1007/s11695-017-2693-7.

    PMID: 28451929BACKGROUND
  • Fayad L, Adam A, Schweitzer M, Cheskin LJ, Ajayi T, Dunlap M, Badurdeen DS, Hill C, Paranji N, Lalezari S, Kalloo AN, Khashab MA, Kumbhari V. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc. 2019 Apr;89(4):782-788. doi: 10.1016/j.gie.2018.08.030. Epub 2018 Aug 25.

    PMID: 30148991BACKGROUND
  • Abu Dayyeh BK, Bazerbachi F, Vargas EJ, Sharaiha RZ, Thompson CC, Thaemert BC, Teixeira AF, Chapman CG, Kumbhari V, Ujiki MB, Ahrens J, Day C; MERIT Study Group; Galvao Neto M, Zundel N, Wilson EB. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022 Aug 6;400(10350):441-451. doi: 10.1016/S0140-6736(22)01280-6. Epub 2022 Jul 28.

    PMID: 35908555BACKGROUND
  • Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008 Jul;68(1):51-8. doi: 10.1016/j.gie.2007.10.061. Epub 2008 Mar 19.

    PMID: 18355825BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativePain

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Luc Karsenty, Professor

    American Hospital of Paris, France

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
anesthesiologist, MD, PhD

Study Record Dates

First Submitted

October 5, 2026

First Posted

October 15, 2026

Study Start

January 1, 2018

Primary Completion

August 31, 2020

Study Completion

August 31, 2020

Last Updated

October 15, 2026

Record last verified: 2026-10

Locations